Terug
Dagbereik
€ 13,62
€ 13,94
52-Weeksbereik
€ 9,53
€ 19,85
Volume
2.752.366
50D / 200D Gem.
€ 16,87
/
€ 15,41
Vorige Slotkoers
€ 13,88
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (627 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 50,5 | 0,4 |
| P/B | 6,5 | 2,9 |
| ROE % | 15,4 | 3,7 |
| Net Margin % | 6,7 | 3,9 |
| Rev Growth 5Y % | 5,7 | 10,0 |
| D/E | 3,8 | 0,2 |
Koersdoel Analisten
Hold
€ 22,67
+63.9%
Low: € 20,00
High: € 24,00
Forward K/W
14,4
Forward WPA
€ 0,96
WPA Groei (sch.)
+0,0%
Omzet Sch.
1,2 B
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2029 |
€ 1,29
€ 1,28 – € 1,30
|
1,5 B | 1 |
| FY2028 |
€ 1,17
€ 1,08 – € 1,26
|
1,4 B | 2 |
| FY2027 |
€ 1,05
€ 1,04 – € 1,06
|
1,3 B | 5 |
Belangrijkste Punten
Revenue grew 5,72% annually over 5 years — modest growth
Earnings grew 75,57% over the past year
ROE of 15,42% — decent returns on equity
Debt/Equity of 3,75 — high leverage
Generating 149,18M in free cash flow
P/E of 50,48 — premium valuation
Groei
Revenue Growth (5Y)
5,72%
Revenue (1Y)5,74%
Earnings (1Y)75,57%
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
15,42%
ROIC10,23%
Net Margin6,70%
Op. Margin33,75%
Veiligheid
Debt / Equity
3,75
Current Ratio2,46
Interest Coverage2,52
Waardering
P/E Ratio
50,48
P/B Ratio6,49
EV/EBITDA14,92
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 5,74% | Revenue Growth (3Y) | 5,31% |
| Earnings Growth (1Y) | 75,57% | Earnings Growth (3Y) | 23,18% |
| Revenue Growth (5Y) | 5,72% | Earnings Growth (5Y) | -9,63% |
| Profitability | |||
| Revenue (TTM) | 1,16B | Net Income (TTM) | 77,95M |
| ROE | 15,42% | ROA | 2,39% |
| Gross Margin | 55,48% | Operating Margin | 33,75% |
| Net Margin | 6,70% | Free Cash Flow (TTM) | 149,18M |
| ROIC | 10,23% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 3,75 | Current Ratio | 2,46 |
| Interest Coverage | 2,52 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | 50,48 | P/B Ratio | 6,49 |
| P/S Ratio | 3,38 | PEG Ratio | 0,93 |
| EV/EBITDA | 14,92 | Dividend Yield | 0,00% |
| Market Cap | 3,93B | Enterprise Value | 5,86B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1,16B | 1,10B | 1,05B | 1,00B | 931,48M |
| Net Income | 77,95M | 44,40M | 51,38M | -233,57M | 116,88M |
| EPS (Diluted) | 0,27 | 0,16 | 0,18 | -0,83 | 0,41 |
| Gross Profit | 645,53M | 602,30M | 577,16M | 557,00M | 518,67M |
| Operating Income | 392,77M | 297,63M | 276,69M | 248,35M | 256,73M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 3,26B | 3,07B | 3,13B | 3,12B | 2,79B |
| Total Liabilities | 2,66B | 2,67B | 2,69B | 2,77B | 2,20B |
| Shareholders' Equity | 606,04M | 404,91M | 443,73M | 350,24M | 586,10M |
| Total Debt | 2,27B | 2,35B | 2,33B | 2,03B | 1,83B |
| Cash & Equivalents | 346,46M | 277,24M | 296,41M | 395,21M | 106,92M |
| Current Assets | 613,41M | 526,04M | 557,24M | 645,01M | 345,96M |
| Current Liabilities | 249,58M | 191,00M | 230,65M | 791,57M | 161,16M |